{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:29Z","timestamp":1791299969192,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1124\/dmd.117.077289","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T20:30:08Z","timestamp":1510691408000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS\/MS Proteomics"],"prefix":"10.1016","volume":"46","author":[{"given":"Sarah","family":"Billington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Salphati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Griffith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowbottom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.077289_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.117.077289_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1124\/dmd.117.077289_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.117.077289_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cld.2008.03.007","article-title":"Hepatitis C virus infection and hepatocellular carcinoma","volume":"12","author":"Blonski","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1124\/dmd.117.077289_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4254\/wjh.v8.i19.785","article-title":"Sofosbuvir\/velpatasvir: a promising combination","volume":"8","author":"Bonaventura","year":"2016","journal-title":"World J Hepatol"},{"issue":"Suppl 1","key":"10.1124\/dmd.117.077289_bib6","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1007\/s001470050459","article-title":"Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization","volume":"11","author":"Colella","year":"1998","journal-title":"Transpl Int"},{"key":"10.1124\/dmd.117.077289_bib7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1124\/dmd.111.043810","article-title":"Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2\/ABCC2): quantification by liquid chromatography\/tandem mass spectrometry","volume":"40","author":"Deo","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.077289_bib9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.117.077289_bib10","first-page":"5141","article-title":"Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells","volume":"47","author":"Fairchild","year":"1987","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.117.077289_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","article-title":"Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths","volume":"229","author":"Fan","year":"1999","journal-title":"Ann Surg"},{"key":"10.1124\/dmd.117.077289_bib12","doi-asserted-by":"crossref","unstructured":"Fong Y, Sun RL, Jarnagin W, and Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790\u2013799, discussion 799\u2013800.","DOI":"10.1097\/00000658-199906000-00005"},{"key":"10.1124\/dmd.117.077289_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.077289_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/dmd.110.032052","article-title":"In vitro to in vivo comparison of the substrate characteristics of sorafenib tosylate toward P-glycoprotein","volume":"38","author":"Gnoth","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib15","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1572-0241.2003.07678.x","article-title":"The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?","volume":"98","author":"Goodgame","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/dmd.117.077289_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiology.195.3.7754011","article-title":"Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging","volume":"195","author":"Hamm","year":"1995","journal-title":"Radiology"},{"key":"10.1124\/dmd.117.077289_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2133\/dmpk.DMPK-11-RG-077","article-title":"Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development","volume":"27","author":"Hanada","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.117.077289_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00004836-200209000-00013","article-title":"Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States","volume":"35","author":"Hassan","year":"2002","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"10.1124\/dmd.117.077289_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2011.01499.x","article-title":"The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*","volume":"18","author":"Hatzakis","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1124\/dmd.117.077289_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-12-109","article-title":"Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance","volume":"12","author":"Heise","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1124\/dmd.117.077289_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/dmd.117.077289_bib22","unstructured":"Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis Infection (2010) Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (Colvin HM, Mitchell AE eds) National Academies Press, US, Washington, DC."},{"key":"10.1124\/dmd.117.077289_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/RLI.0b013e3182a70043","article-title":"Characterization of the intestinal and hepatic uptake\/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid","volume":"49","author":"Jia","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1124\/dmd.117.077289_bib24","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1124\/dmd.114.059097","article-title":"Selective inhibition of human solute carrier transporters by multikinase inhibitors","volume":"42","author":"Johnston","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/FPC.0b013e32830d733e","article-title":"Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide","volume":"18","author":"Kalliokoski","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.117.077289_bib26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.117.077289_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.34851","article-title":"Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci","volume":"36","author":"Kinoshita","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.077289_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.10092214","article-title":"Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features","volume":"256","author":"Kitao","year":"2010","journal-title":"Radiology"},{"key":"10.1124\/dmd.117.077289_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1734-1140(12)70888-5","article-title":"Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1","volume":"64","author":"Kurzawski","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1124\/dmd.117.077289_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1535-7163.MCT-09-0663","article-title":"Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulation","volume":"9","author":"Lagas","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.117.077289_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.117.077289_bib35","doi-asserted-by":"crossref","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095\u20132128.","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"10.1124\/dmd.117.077289_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.1840150603","article-title":"Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver","volume":"15","author":"McGuire","year":"1992","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.077289_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.117.077289_bib38","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1124\/dmd.107.020073","volume":"36","author":"Nakai","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00535-009-0056-4","article-title":"Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma","volume":"44","author":"Narita","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1124\/dmd.117.077289_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm405","article-title":"Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1","volume":"5","author":"Nies","year":"2013","journal-title":"Genome Med"},{"key":"10.1124\/dmd.117.077289_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2133\/dmpk.25.190","article-title":"Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters","volume":"25","author":"Ogasawara","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.117.077289_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cpt.437","article-title":"Transport vs. metabolism: what determines the pharmacokinetics and pharmacodynamics of drugs? insights from the extended clearance model","volume":"100","author":"Patilea-Vrana","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.077289_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/dmd.113.053819","article-title":"Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex","volume":"42","author":"Prasad","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt.409","article-title":"Ontogeny of hepatic drug transporters as quantified by LC-MS\/MS proteomics","volume":"100","author":"Prasad","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.077289_bib45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jps.23436","article-title":"Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP\/ABCG2): effect of age, sex, and genotype","volume":"102","author":"Prasad","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.117.077289_bib46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1208\/s12248-014-9602-y","article-title":"Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics","volume":"16","author":"Prasad","year":"2014","journal-title":"AAPS J"},{"key":"10.1124\/dmd.117.077289_bib47","doi-asserted-by":"crossref","first-page":"18880","DOI":"10.2807\/ese.13.21.18880-en","article-title":"Surveillance and epidemiology of hepatitis B and C in Europe - a review","volume":"13","author":"Rantala","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1124\/dmd.117.077289_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/path.1379","article-title":"High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease","volume":"200","author":"Ros","year":"2003","journal-title":"J Pathol"},{"key":"10.1124\/dmd.117.077289_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jnutbio.2014.09.008","article-title":"Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking","volume":"26","author":"Saeed","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1124\/dmd.117.077289_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/gm298","article-title":"DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma","volume":"3","author":"Schaeffeler","year":"2011","journal-title":"Genome Med"},{"key":"10.1124\/dmd.117.077289_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","article-title":"Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system","volume":"183","author":"Schuhmann-Giampieri","year":"1992","journal-title":"Radiology"},{"key":"10.1124\/dmd.117.077289_bib52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/dmd.112.048181","article-title":"Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites","volume":"41","author":"Swift","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2016.01.054","article-title":"Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: pharmacokinetic and pharmacodynamic investigations","volume":"501","author":"Tariq","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.117.077289_bib54","doi-asserted-by":"crossref","unstructured":"Terrault NA, Zeuzem S, Di Bisceglie AM, Lim JK, Pockros PJ, Frazier LM, Kuo A, Lok AS, Shiffman ML, Ben Ari Z et al. HCV-TARGET Study Group (2016) Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response. Gastroenterology 151:1131\u20131140.e5.","DOI":"10.1053\/j.gastro.2016.08.004"},{"key":"10.1124\/dmd.117.077289_bib55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.10091557","article-title":"Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation","volume":"255","author":"Tsuboyama","year":"2010","journal-title":"Radiology"},{"key":"10.1124\/dmd.117.077289_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-011-1099-5","article-title":"OATP 1B1\/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation","volume":"459","author":"Vasuri","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1124\/dmd.117.077289_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2003.10.008","article-title":"The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma","volume":"40","author":"Vavricka","year":"2004","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.117.077289_bib58","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1124\/dmd.116.071050","article-title":"Transporter expression in liver tissue from subjects with alcoholic or hepatitis C cirrhosis quantified by targeted quantitative proteomics","volume":"44","author":"Wang","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077289_bib60","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1535-7163.MCT-12-0215","article-title":"New use for an old drug: inhibiting ABCG2 with sorafenib","volume":"11","author":"Wei","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.117.077289_bib61","unstructured":"World Health Organization (2017) Global Hepatitis Report 2017, Geneva, Switzerland: World Health Organization."},{"key":"10.1124\/dmd.117.077289_bib62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.106.110346","article-title":"Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)","volume":"319","author":"Yonezawa","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.077289_bib63","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/1078-0432.CCR-12-3306","article-title":"Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide","volume":"19","author":"Zimmerman","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.117.077289_bib64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","article-title":"Hepatobiliary transporter expression in human hepatocellular carcinoma","volume":"25","author":"Zollner","year":"2005","journal-title":"Liver Int"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.077289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:32:53Z","timestamp":1739903573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624054333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0090955624054333"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.077289","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS\/MS Proteomics","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.077289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}